NCT04504942 2026-01-23
Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors
CytoDyn, Inc.
Phase 2 Completed
CytoDyn, Inc.
Yancheng First People's Hospital
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Columbia University
Swiss Cancer Institute
NYU Langone Health
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
St. Jude Children's Research Hospital